Alfresa’s Strengths
Alfresa leverages its five refined strengths to contribute to medical care institutions, patients, local communities, and domestic and international companies.
-
01Advanced logistics functions
Alfresa’s goal: “Safe and secure pharmaceutical logistics”
Learn more about Advanced logistics capabilities
Business Introduction
We take pride in our mission, which is to protect the everyday reality that medicine is available here, right now, through pharmaceutical distribution.
We deliver products such as ethical pharmaceuticals, diagnostic reagents, medical devices, and equipment from our nationwide distribution centers with high processing capabilities to hospitals, clinics, and dispensing pharmacies.
Our sales staff also have extensive knowledge and expertise to support our customers.
Services
We introduce services that contribute to the overall convenience of the medical care and nursing care industries by supporting the efficiency of medical care settings and facilitating smooth communication through online tools and information provision.
View details of our services
Notice
- PR information Notice Regarding Alliance Between Alfresa Corporation, CMIC HOLDINGS Co., Ltd., and CMIC Trust Co., Ltd. for the Establishment of Comprehensive Vaccination Support Platforms
- PR information Notice Regarding Basic Business Alliance Agreement between Alfresa Corporation and K Pharma, Inc. Regarding the Supply Chain for iPS Cell-Derived Regenerative Medicine Products and Investment Agreement Regarding Bonds with Share Acquisition Rights Issued
- PR information Investment in SBI Investment Limited Partnership Venture Fund 2023 by Alfresa Corporation
- PR information Realization of Regular Drone-Based Deliveries of Pharmaceuticals in Accordance with Guidelines
- Others Notice regarding Alfresa Group Companies Recognized as the 2025 Outstanding Organizations of KENKO Investment for Health Program
- PR information Notice Regarding Alliance Between Alfresa Corporation, CMIC HOLDINGS Co., Ltd., and CMIC Trust Co., Ltd. for the Establishment of Comprehensive Vaccination Support Platforms
- PR information Notice Regarding Basic Business Alliance Agreement between Alfresa Corporation and K Pharma, Inc. Regarding the Supply Chain for iPS Cell-Derived Regenerative Medicine Products and Investment Agreement Regarding Bonds with Share Acquisition Rights Issued
- PR information Investment in SBI Investment Limited Partnership Venture Fund 2023 by Alfresa Corporation
- PR information Realization of Regular Drone-Based Deliveries of Pharmaceuticals in Accordance with Guidelines
- PR information Notice Regarding Achievement of ISO 9001 Certification by Alfresa Corporation Efforts to Improve Logistics Quality in the Alfresa Group










